Sterile RTU molded vials: SGD Pharma joins Ompi EZ-fill® platform
Pharmapack, Paris, 10-11th February 2016
SGD Pharma announces its partnership with the Ompi EZ-fill® platform in order to offer sterile and depyrogenated vials to the parenteral market.
SGD Pharma will be the first molded glass supplier to offer RTU vials through the Ompi EZ-fill® platform created by Ompi, the Italian leading supplier in the sterile glass vials industry.
The platform has been created by Ompi at first for syringes (2007) and then it was extended in 2010 to vials and cartridges. The Ompi EZ-fill® platform offers four main advantages:
- Maximizes flexibility in aseptic filling that can be integrated into the already existing pharmaceutical manufacturing filling lines;
- Provides less time to market which is the perfect solution both during clinical trials and during the industrialization phase;
- Offers maximum safety during the transportation phase and in the buffering/in-feeding operations;
- Reduces the total cost of ownership enabling pharmaceutical companies to outsource their non-core activities, to lower footprint and to reduce costs.
Alessandro Massignani, Ompi EZ-fill® Vials & Cartridges Product Manager at Ompi Pharmaceutical Systems declared «We are pleased to welcome SGD Pharma as our first partner on the Ompi EZ-fill® platform. This confirm our capability toto offer a complete range of sterile primary packaging to answer the expectations of pharma and biotech companies in ready-to-fill solutions ».
Vincent LANGLADE, marketing director of SGD Pharma added “By joining Ompi EZ-fill®, SGD Pharma adds new solutions in vials filling and brings significant added value to its clients. We are also excited to participate in setting the next standard for RTU vials”.
STOP AT SGD PHARMA STAND 620 to lean more
About SGD Pharma
SGD Pharma is an independent company, global leader in the glass packaging solutions for the pharmaceutical industry. With a long glass know-know developed for more than a century in France, SGD Pharma offers a broad range of glass types (I,II,III) for pharmaceutical containers including injectable, infusion, diagnostic and syrup bottles.
SGD Pharma operates a global footprint of 5 manufacturing sites in Europe and Asia and 10 commercial hubs throughout the world. The company manufactures more than 2 billion glass containers every year and has more than 1500 employees worldwide.
For more information www.sgd-pharma.com
Media contacts for SGD Pharma
Charlotte Barberet, SGD Pharma Market and communication manager
Tel.: + 33 (0)1 40 90 36 62 - email@example.com
Sophie Ryan, LPM Communications
Tel.: + 33 1 44 50 40 39 - firstname.lastname@example.org
About Ompi and Ompi EZ-fill®
Ompi is the Pharmaceutical Systems division of Stevanato Group. It has more than 65 years’ experience in the production of glass primary packaging for the pharmaceutical industry: ampoules, vials, cartridges and syringes, both in bulk and sterile format. It is well positioned to serve the future needs of its clients with production sites located throughout the world: Piombino Dese-Padua and Latina in Italy, Bratislava in Slovakia, Monterrey in Mexico (supported by a sales office in the USA),Zhangjiagang, in China and a plant under construction in Brazil
Media contacts for Ompi
Image Building Media Relations
Tel: + 39 02 89011300
Released February 10, 2016